Invention Grant
- Patent Title: Functional assay for cancer recurrence and malignant potential
-
Application No.: US14424948Application Date: 2013-08-14
-
Publication No.: US10295530B2Publication Date: 2019-05-21
- Inventor: Sandra S. McAllister , Zafira Castano
- Applicant: THE BRIGHAM AND WOMEN'S HOSPITAL, INC.
- Applicant Address: US MA Boston
- Assignee: The Brigham and Women's Hospital, Inc.
- Current Assignee: The Brigham and Women's Hospital, Inc.
- Current Assignee Address: US MA Boston
- Agency: Nixon Peabody LLP
- International Application: PCT/US2013/054859 WO 20130814
- International Announcement: WO2014/035668 WO 20140306
- Main IPC: G01N33/50
- IPC: G01N33/50 ; G01N33/574 ; C12Q1/6886

Abstract:
Embodiments herein provides an in vitro co-culture system comprising a population of cancer responder cells and a population of non-tumor cells wherein the cancer responder cells can convert to a malignant state and exhibit hallmark malignant phenotype when the cells are placed in a tumor supportive environment. The system is useful for prognosis evaluation of cancer recurrence, malignancy development, cancer drug screening and surveillance for resistance to cancer drug therapy.
Public/Granted literature
- US20150212072A1 FUNCTIONAL ASSAY FOR CANCER RECURRENCE AND MALIGNANT POTENTIAL Public/Granted day:2015-07-30
Information query
IPC分类: